Of note, this TGF-β inhibitor was used in our study to dissect the cellular mechanisms of cardiogenic dementia, but its potential as a drug candidate remains uncertain because of its cardiac toxicity and the side effects of blocking the physiological TGF-β signaling in healthy cells71. Here, TGFB1 is linked to dementia.